|
| (+/-)-alpha-Lipoamide Basic information |
Product Name: | (+/-)-alpha-Lipoamide | Synonyms: | DL-ALPHA-LIPOAMIDE;DL-6,8-THIOCTIC ACID AMIDE OXIDIZED FORM;DL-6,8-EPIDITHIOOCTANAMIDE;DL-6,8-THIOCTAMIDE;DL-6,8-THIOCTIC ACID AMIDE;DL-THIOCTAMIDE;DL-LIPOAMIDE OXIDIZED FORM;6-THIOCTIC AMIDE | CAS: | 940-69-2 | MF: | C8H15NOS2 | MW: | 205.34 | EINECS: | 213-375-2 | Product Categories: | Heterocyclic Compounds | Mol File: | 940-69-2.mol | |
| (+/-)-alpha-Lipoamide Chemical Properties |
Melting point | 127-129 °C(lit.) | Boiling point | 399.2±11.0 °C(Predicted) | density | 1.1989 (rough estimate) | refractive index | 1.5364 (estimate) | storage temp. | Sealed in dry,2-8°C | solubility | Dichloromethane (Slightly), DMSO (Slightly, Heated, Sonicated), Ethanol (Slightly) | pka | 16.59±0.40(Predicted) | form | Solid | color | Pale Yellow to Yellow | CAS DataBase Reference | 940-69-2(CAS DataBase Reference) |
Hazard Codes | Xn | Risk Statements | 22 | Safety Statements | 22-24/25 | WGK Germany | 3 | RTECS | JP1185000 |
| (+/-)-alpha-Lipoamide Usage And Synthesis |
Uses | (±)-α-Lipoamide may be used in treatment of insulin resistance by stimulating mitochondrial biogenesis. When used in combination with Alprostadil, it has shown to have a good therapeutic effect on early diabetic nephropathy. | Definition | ChEBI: A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of lipoic acid with ammonia. | storage | Store at -20°C | Purification Methods | DL--Lipoamide is recrystallised from EtOH and has UV with max 331nm in MeOH. [Reed et al. J Biol Chem 232 143 1958, IR: Wagner et al. J Am Chem Soc 78 5079 1956, Beilstein 19/7 V 238.] |
| (+/-)-alpha-Lipoamide Preparation Products And Raw materials |
|